Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
BJU International|August 28, 2009
Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening populationDavid J Kaplan, Stephen A Boorjian, Karen Ruth, et al.
European Urology|April 8, 2018
Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical OutcomesAndrew G McIntosh, Benjamin T Ristau, Karen Ruth, et al.
JAMA Oncology|December 15, 2015
Time to Surgery and Breast Cancer Survival in the United StatesRichard J Bleicher, Karen Ruth, Elin R Sigurdson, et al.
Nature Communications|November 28, 2017
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosisSuraj Peri, Evgeny Izumchenko, Adrian D Schubert, et al.
Ophthalmology|June 21, 2011
Survey of Trachoma within school students in the state of Roraima, BrazilNorma Helen Medina, Maria de Fatima Lopes, Shane R Durkin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 26, 2009
Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk menVeda N Giri, Brian Egleston, Karen Ruth, et al.
Urologic Oncology|December 31, 2022
No difference in renal function outcomes for patients with oncocytoma managed with active surveillance vs. partial nephrectomyKevin B Ginsburg, Marshall Strother, Jared P Schober, et al.
Pageof 9